Features characteristic to rheumatoid joint destruction, including synovial overgrowth and bone resorption, are experimentally produced by augmenting c-fos gene expression. We tested here if arthritic joint destruction was inhibited upon inactivation of the c-fos/AP-1 signal by administering short double-stranded AP-1 DNA oligonucleotides into mice with collagen-induced arthritis to compete for the binding of AP-1 in vivo at the promoter binding site. Arthritic joint destruction was inhibited in a sequence-specific and dose-dependent manner by oligonucleotides containing the AP-1 sequence. The oligonucleotides inhibited gene expression at the transcriptional level. Nucleotide sequences besides AP-1 also appeared to be important structurally for binding of AP-1 onto DNA and for the stability of oligonucleotides against nucleases. Immunohistochemical chase experiment administering biotinylated oligonucleotides into arthritic mice showed that AP-1 oligonucleotides reached the inflamed joint. Thus, activation of c-fos/AP-1 appears essentially important in arthritic joint destruction.
S Shiozawa, K Shimizu, K Tanaka, K Hino
Title and authors | Publication | Year |
---|---|---|
The universal role of adaptive transcription in health and disease.
Lissek T |
The FEBS journal | 2024 |
Drivers of heterogeneity in synovial fibroblasts in rheumatoid arthritis.
Smith MH, Gao VR, Periyakoil PK, Kochen A, DiCarlo EF, Goodman SM, Norman TM, Donlin LT, Leslie CS, Rudensky AY |
Nature Immunology | 2023 |
Integration of ATAC-seq and RNA-seq identifies MX1-mediated AP-1 transcriptional regulation as a therapeutic target for Down syndrome.
Guo Z, Zhu Y, Xiao H, Dai R, Yang W, Xue W, Zhang X, Hao B, Liao S |
Biological research | 2023 |
Engineered synthetic cell penetrating peptide with intracellular anti‐inflammatory bioactivity: An in vitro and in vivo study
JY Lee, DW Lee, BS Jo, KS Park, YS Park, CP Chung, YJ Park |
Journal of biomedical materials research. Part A | 2021 |
Follistatin-like 1 in Cardiovascular Disease and Inflammation
MM Peters, TA Meijs, W Gathier, PA Doevendans, JP Sluijter, SA Chamuleau, K Neef |
Mini reviews in medicinal chemistry | 2019 |
Astragalin Suppresses Inflammatory Responses and Bone Destruction in Mice With Collagen-Induced Arthritis and in Human Fibroblast-Like Synoviocytes
Q Jia, T Wang, X Wang, H Xu, Y Liu, Y Wang, Q Shi, Q Liang |
Frontiers in pharmacology | 2019 |
Chondroprotective effects of aqueous extract of Anthriscus sylvestris leaves on osteoarthritis in vitro and in vivo through MAPKs and NF-κB signaling inhibition
SA Lee, SM Moon, SH Han, EJ Hwang, BR Park, JS Kim, DK Kim, CS Kim |
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie | 2018 |
Potential in vitro and ex vivo targeting of bZIP53 involved in stress response and seed maturation in Arabidopsis thaliana by five designed peptide inhibitors
P Jain, K Shah, V Rishi |
Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics | 2018 |
Terpenes as possible drugs for the mitigation of arthritic symptoms - a systematic review
AM Carvalho, L Heimfarth, KA Santos, AG Guimarães, L Picot, JR Almeida, JS Quintans, LJ Quintans-Júnior |
Phytomedicine : international journal of phytotherapy and phytopharmacology | 2018 |
A wogonin-rich-fraction of Scutellaria baicalensis root extract exerts chondroprotective effects by suppressing IL-1β-induced activation of AP-1 in human OA chondrocytes
NM Khan, A Haseeb, MY Ansari, TM Haqqi |
Scientific Reports | 2017 |
Harpagoside suppresses IL-6 expression in primary human osteoarthritis chondrocytes: Harpagoside inhibits IL-6 and c-FOS/AP-1
A Haseeb, MY Ansari, TM Haqqi |
Journal of Orthopaedic Research | 2016 |
Small Molecule Inhibitors Targeting Activator Protein 1 (AP-1)
N Ye, Y Ding, C Wild, Q Shen, J Zhou |
Journal of Medicinal Chemistry | 2014 |
Chemical constituents of Plectranthus amboinicus and the synthetic analogs possessing anti-inflammatory activity
YS Chen, HM Yu, JJ Shie, TJ Cheng, CY Wu, JM Fang, CH Wong |
Bioorganic & Medicinal Chemistry | 2014 |
Soft Coral-Derived Lemnalol Alleviates Monosodium Urate-Induced Gouty Arthritis in Rats by Inhibiting Leukocyte Infiltration and iNOS, COX-2 and c-Fos Protein Expression
HP Lee, SY Huang, YY Lin, HM Wang, YH Jean, SF Wu, CY Duh, ZH Wen |
Marine drugs | 2013 |
N-(2-hydroxy phenyl) acetamide produces profound inhibition of c-Fos protein and mRNA expression in the brain of adjuvant-induced arthritic rats
H Jawed, S Jamall, SU Shah, K Perveen, F Hanif, SU Simjee |
Molecular and Cellular Biochemistry | 2013 |
c-Jun N-Terminal Kinase in Inflammation and Rheumatic Diseases
M Guma, GS Firestein |
The open rheumatology journal | 2012 |
Small-molecule inhibitors of dimeric transcription factors: Antagonism of protein–protein and protein–DNA interactions
JL Yap, J Chauhan, KY Jung, L Chen, EV Prochownik, S Fletcher |
MedChemComm | 2012 |
A Systems Approach to Rheumatoid Arthritis
S You, CS Cho, I Lee, L Hood, D Hwang, WU Kim, MA Mancini |
PloS one | 2012 |
Pathogenesis of Joint Destruction in Rheumatoid Arthritis
S Shiozawa, K Tsumiyama, K Yoshida, A Hashiramoto |
Archivum Immunologiae et Therapiae Experimentalis | 2011 |
A mixture of Trachelospermi caulis and Moutan cortex radicis extracts suppresses collagen-induced arthritis in mice by inhibiting NF-κB and AP-1 : Anti-arthritic herbal mixture
HS Kim, AR Kim, JM Lee, SN Kim, JH Choi, DK Kim, JH Kim, B Kim, E Her, YM Yang, HS Kim, YM Kim, WS Choi |
Journal of Pharmacy and Pharmacology | 2011 |
Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis
B Bartok, GS Firestein |
Immunological Reviews | 2010 |
Heat shock protein 90 maintains the tumour-like character of rheumatoid synovial cells by stabilizing integrin-linked kinase, extracellular signal-regulated kinase and protein kinase B
A Hashiramoto, M Murata, T Kawazoe, K Yoshida, C Akiyama, K Shiozawa, S Shiozawa |
Rheumatology | 2010 |
Interactions between the genes that regulate the body clock and those that worsen rheumatoid arthritis
S Shiozawa, A Hashiramoto |
Expert Review of Clinical Immunology | 2010 |
IL-3 inhibits TNF-alpha-induced bone resorption and prevents inflammatory arthritis
SD Yogesha, SM Khapli, RK Srivastava, LS Mangashetti, ST Pote, GC Mishra, MR Wani |
Journal of immunology (Baltimore, Md. : 1950) | 2009 |
Mammalian Clock Gene Cryptochrome Regulates Arthritis via Proinflammatory Cytokine TNF-α
A Hashiramoto, T Yamane, K Tsumiyama, K Yoshida, K Komai, H Yamada, F Yamazaki, M Doi, H Okamura, S Shiozawa |
Journal of immunology (Baltimore, Md. : 1950) | 2009 |
Treatment of arthritis with a selective inhibitor of c-Fos/activator protein-1
Y Aikawa, K Morimoto, T Yamamoto, H Chaki, A Hashiramoto, H Narita, S Hirono, S Shiozawa |
Nature Biotechnology | 2008 |
A triple altered collagen II peptide with consecutive substitutions of TCR contacting residues inhibits collagen-induced arthritis
ZQ Yao, R Li, ZG Li |
Annals of the rheumatic diseases | 2007 |
p38 MAP Kinase inhibitor
M NISHIKAWA, A MYOUI, T TOMITA, K TAKAHI, A NAMPEI, H YOSHIKAWA |
Japanese Journal of Clinical Immunology | 2007 |
Inhibitory effect of ribbon-type NF-kappaB decoy oligodeoxynucleotides on osteoclast induction and activity in vitro and in vivo
Y Kunugiza, T Tomita, N Tomita, R Morishita, H Yoshikawa |
Arthritis Research & Therapy | 2006 |
Mechanisms of Disease: transcription factors in inflammatory arthritis
D Aud, SL Peng |
Nature Clinical Practice Rheumatology | 2006 |
Gene therapy for arthritis: What next?
CH Evans, SC Ghivizzani, PD Robbins |
Arthritis & Rheumatism | 2006 |
Punica granatum L. extract inhibits IL-1beta-induced expression of matrix metalloproteinases by inhibiting the activation of MAP kinases and NF-kappaB in human chondrocytes in vitro
S Ahmed, N Wang, BB Hafeez, VK Cheruvu, TM Haqqi |
The Journal of nutrition | 2005 |
Use of local electroporation enhances methotrexate effects with minimum dose in adjuvant-induced arthritis
M Tada, K Inui, T Koike, K Takaoka |
Arthritis & Rheumatism | 2005 |
Herbal Medications Commonly Used in the Practice of Rheumatology: Mechanisms of Action, Efficacy, and Side Effects
AR Setty, LH Sigal |
Seminars in Arthritis and Rheumatism | 2005 |
Punica granatum L. Extract Inhibits IL-1β–Induced Expression of Matrix Metalloproteinases by Inhibiting the Activation of MAP Kinases and NF-κB in Human Chondrocytes In Vitro
S Ahmed, N Wang, BB Hafeez, VK Cheruvu, TM Haqqi |
The Journal of nutrition | 2005 |
Antirheumatic Therapy: Actions and Outcomes
RO Day, DE Fürst, PL van Riel, B Bresnihan |
2005 | |
Discovery of Nonpeptidic Small-Molecule AP-1 Inhibitors: Lead Hopping Based on a Three-Dimensional Pharmacophore Model
K Tsuchida, H Chaki, T Takakura, H Kotsubo, T Tanaka, Y Aikawa, S Shiozawa, S Hirono |
Journal of Medicinal Chemistry | 2005 |
Ameliorative effects of follistatin-related protein/TSC-36/FSTL1 on joint inflammation in a mouse model of arthritis
D Kawabata, M Tanaka, T Fujii, H Umehara, Y Fujita, H Yoshifuji, T Mimori, S Ozaki |
Arthritis & Rheumatism | 2004 |
Interleukin-17 signal transduction pathways implicated in inducing matrix metalloproteinase-3, -13 and aggrecanase-1 genes in articular chondrocytes
J Sylvester, A Liacini, WQ Li, M Zafarullah |
Cellular Signalling | 2004 |
Human wee1 kinase is directly transactivated by and increased in association with c-Fos/AP-1: rheumatoid synovial cells overexpressing these genes go into aberrant mitosis
H Kawasaki, K Komai, M Nakamura, E Yamamoto, Z Ouyang, T Nakashima, T Morisawa, A Hashiramoto, K Shiozawa, H Ishikawa, M Kurosaka, S Shiozawa |
Oncogene | 2003 |
IL-6 and matrix metalloproteinase-1 are regulated by the cyclin-dependent kinase inhibitor p21 in synovial fibroblasts
H Perlman, K Bradley, H Liu, S Cole, E Shamiyeh, RC Smith, K Walsh, S Fiore, AE Koch, GS Firestein, GK 3rd, RM Pope |
Journal of immunology (Baltimore, Md. : 1950) | 2003 |
Interleukins in Atherosclerosis: Molecular Pathways and Therapeutic Potential
JH der Thüsen, J Kuiper, TJ Berkel, EA Biessen |
Pharmacological reviews | 2003 |
Evolving concepts of rheumatoid arthritis
GS Firestein |
Nature | 2003 |
p21waf1/cip1 is down-regulated in conjunction with up-regulation of c-Fos in the lymphocytes of rheumatoid arthritis patients
M Hikasa, E Yamamoto, H Kawasaki, K Komai, K Shiozawa, A Hashiramoto, Y Miura, S Shiozawa |
Biochemical and Biophysical Research Communications | 2003 |
Prevention of the onset and progression of collagen-induced arthritis in rats by the potent p38 mitogen-activated protein kinase inhibitor FR167653
M Nishikawa, A Myoui, T Tomita, K Takahi, A Nampei, H Yoshikawa |
Arthritis & Rheumatism | 2003 |
Regulation of matrix metalloproteinases: an overview
Sajal Chakraborti, Malay Mandal, Sudip Das, Amritlal Mandal, Tapati Chakraborti |
Molecular and Cellular Biochemistry | 2003 |
Cytokine inhibitors in the treatment of rheumatoid arthritis
C Gabay |
Expert Opinion on Biological Therapy | 2002 |
Matrix metalloproteinases as therapeutic targets in arthritic diseases: Bull's-eye or missing the mark?
JA Mengshol, KS Mix, CE Brinckerhoff |
Arthritis & Rheumatism | 2002 |
c-Fos/activator protein-1 transactivates wee1 kinase at G(1)/S to inhibit premature mitosis in antigen-specific Th1 cells
H Kawasaki, K Komai, Z Ouyang, M Murata, M Hikasa, M Ohgiri, S Shiozawa |
The EMBO Journal | 2001 |
PATHOGENESIS OF RHEUMATOID ARTHRITIS: THE ROLE OF SYNOVIOCYTES
Y Yamanishi, GS Firestein |
Rheumatic Disease Clinics of North America | 2001 |
Gene therapy for rheumatoid arthritis
E Gouze, SC Ghivizzani, PD Robbins, CH Evans |
Current Rheumatology Reports | 2001 |
Proteases in invasion: matrix metalloproteinases
WG Stetler-Stevenson, AE Yu |
Seminars in Cancer Biology | 2001 |
Synergistic induction of matrix metalloproteinase 1 by interleukin-1? and oncostatin M in human chondrocytes involves signal transducer and activator of transcription and activator protein 1 transcription factors via a novel mechanism
JB Catterall, S Carr�re, PJ Koshy, BA Degnan, WD Shingleton, CE Brinckerhoff, J Rutter, TE Cawston, AD Rowan |
Arthritis & Rheumatism | 2001 |
Gene therapy in rheumatic diseases
MJ Vervoordeldonk, PP Tak |
Best Practice & Research Clinical Rheumatology | 2001 |
In VivoInhibition of Cyclooxygenase-2 by a Selective Phosphorothioated Oligonucleotide
I Khan, FM Al-Awadi, N Thomas |
Antisense and Nucleic Acid Drug Development | 2001 |
Impact of transcription factors AP-1 and NF-κB on the outcome of experimental Staphylococcus aureus arthritis and sepsis
I Gjertsson, OH Hultgren, LV Collins, S Pettersson, A Tarkowski |
Microbes and Infection | 2001 |
GENE THERAPY FOR RHEUMATOID ARTHRITIS
JN Gouze, SC Ghivizzani, E Gouze, GD Palmer, OB Betz, PD Robbins, CH Evans, JH Herndon |
Hand Surgery | 2001 |
The possible role of c-fos expression in rheumatoid joint destruction
M Tsuji, M Tanaka, H Hayashi, S Koshiishi, K Fujii |
Modern Rheumatology | 2001 |
Therapeutic Immunosuppression
AW Thomson |
2001 | |
IL-1 inhibitors: novel agents in the treatment of rheumatoid arthritis
C Gabay |
Expert Opinion on Investigational Drugs | 2000 |
Identification of multiple cis-acting elements mediating the induction of prostaglandin G/H synthase-2 by phorbol ester in murine osteoblastic cells
Y Okada, O Voznesensky, H Herschman, J Harrison, C Pilbeam |
Journal of Cellular Biochemistry | 2000 |
Spontaneous and cytokine regulated c-fos gene expression in rheumatoid synovial cells: resistance to cytokine stimulation when the c-fos gene is overexpressed
K Shimizu, H Kawasaki, T Morisawa, M Nakamura, E Yamamoto, N Yoshikawa, M Doita, K Shiozawa, S Yonehara, K Chihara, S Shiozawa |
Annals of the rheumatic diseases | 2000 |
Selective Inhibition of Cyclooxygenase-2 with Antisense Oligodeoxynucleotide Restricts Induction of Rat Adjuvant-Induced Arthritis
R Yamada, H Sano, T Hla, A Hashiramoto, Y Kawahito, S Mukai, M Kohno, Y Tsubouchi, M Inoue, A Komatsu, K Inoue, M Kondo |
Biochemical and Biophysical Research Communications | 2000 |
Inhibition Of Transcription Factors By Anti-Inflammatory And Anti-Rheumatic Drugs: Can Variability In Response Be Overcome?
ML Handel, LQ Nguyen, TP Lehmann |
Clinical and Experimental Pharmacology and Physiology | 2000 |
Inflammation and Native American medicine: the role of botanicals
AT Borchers, CL Keen, JS Stern, ME Gershwin |
The American journal of clinical nutrition | 2000 |
Gene Therapy in Inflammatory Diseases
CH Evans, PD Robbins |
2000 | |
Type IIA Secretory Phospholipase A 2 Up-Regulates Cyclooxygenase-2 and Amplifies Cytokine-Mediated Prostaglandin Production in Human Rheumatoid Synoviocytes
MJ Bidgood, OS Jamal, AM Cunningham, PM Brooks, KF Scott |
Journal of immunology (Baltimore, Md. : 1950) | 2000 |
Gene therapy for autoimmune disorders
C H Evans, S C Ghivizzani, T J Oligino, P D Robbins |
Journal of Clinical Immunology | 2000 |
The use of gene therapy in osteoarthritis: present and future
JC Fernandes, J Martel-Pelletier, JP Pelletier |
Current Opinion in Orthopedics | 1999 |
Plant extracts from stinging nettle (Urtica dioica), an antirheumatic remedy, inhibit the proinflammatory transcription factor NF-κB
K Riehemann, B Behnke, K Schulze-Osthoff |
FEBS Letters | 1999 |
Increased c-Fos/activator protein-1 confers resistance against anergy induction on antigen-specific T cell
H Kawasaki, Y Nakata, G Suzuki, K Chihara, T Tokuhisa, S Shiozawa |
International Immunology | 1999 |
Signal transduction and transcription factors in rheumatic disease
GS Firestein, AM Manning |
Arthritis & Rheumatism | 1999 |
Regulation of matrix metalloproteinase expression in tumor invasion
J Westermarck, VM Kähäri |
The FASEB Journal | 1999 |
Mechanical Loading of Bones and Joints
HE Takahashi |
1999 | |
Structure of the human histamine H1 receptor gene
MD de Backer, I Loonen, P Verhasselt, JM Neefs, WH Luyten |
Biochemical Journal | 1998 |
Gene therapy in autoimmune diseases
CH Evans, JD Whalen, CH Evans, SC Ghivizzani, PD Robbins |
Annals of the rheumatic diseases | 1998 |
Treatment of rheumatoid arthritis with IL-1 inhibitors
C Gabay, WP Arend |
Springer Seminars in Immunopathology | 1998 |
Transcription factors
PJ Barnes, IM Adcock |
Clinical & Experimental Allergy | 1995 |